Proteomic analysis of pleural effusion from lung adenocarcinoma patients by shotgun strategy

被引:15
|
作者
Sheng, Shu-hong [1 ]
Zhu, Hui-li [1 ]
机构
[1] Fudan Univ, Huadong Hosp, Dept Resp Med, Shanghai 200040, Peoples R China
关键词
Biomarker; Malignant pleural effusion; Proteomic; Shotgun; MASS-SPECTROMETRY; 2-DIMENSIONAL ELECTROPHORESIS; CELL-LINES; GENE; PROTEINS; IDENTIFICATION; RECOGNITION; DISCOVERY; DYNAMICS; DOMAINS;
D O I
10.1007/s12094-013-1054-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To construct a protein catalogue of malignant pleural effusion from lung adenocarcinoma patients and to screen the potential candidates of biomarkers for diagnostic value in human lung adenocarcinoma. Five malignant pleural effusion samples of lung adenocarcinoma patients were collected from January 2009 to September. A composite sample was analyzed using shotgun strategy. Pleural effusion samples were separated by means of SDS-PAGE. Proteomic analysis was performed by 1D-LC-MS/MS, and then the proteins were identified using SEQUEST software and protein database search. Among 230 unique proteins, 123 proteins were identified with higher confidence levels (at least two unique peptide sequences matched). Most of these proteins have been reported in plasma. However, there are 7 proteins, including JUP protein, suprabasin, annexin A2, transforming growth factor-beta-induced protein ig-h3 (beta ig-h3), V-set and immunoglobulin domain-containing protein 4 precursor, ifapsoriasin 2 and actin, cytoplasmic 1 have not been reported in serum. Seven proteins may represent potential candidates of biomarkers. Annexin A2 is of special interest since it may play a role in the regulation of intercellular adhesion and cell proliferation.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 50 条
  • [1] Proteomic analysis of pleural effusion from lung adenocarcinoma patients by shotgun strategy
    Shu-hong Sheng
    Hui-li Zhu
    Clinical and Translational Oncology, 2014, 16 : 153 - 157
  • [2] Construction and analysis of expression profile of exosomal lncRNAs in pleural effusion in lung adenocarcinoma
    Huang, Xiaolu
    Zhou, Huixin
    Yang, Xiang
    Shi, Wenjing
    Hu, Lijuan
    Wang, Junjun
    Zhang, Fan
    Shao, Fanggui
    Zhang, Meijuan
    Jiang, Feng
    Wang, Yumin
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (12)
  • [3] Clinical impact of pleural fluid carcinoembryonic antigen on therapeutic strategy and efficacy in lung adenocarcinoma patients with malignant pleural effusion
    Lee, Jaehee
    Lee, Deok Heon
    Park, Ji Eun
    Lee, Yong Hoon
    Ha Choi, Sun
    Seo, Hyewon
    Yoo, Seung Soo
    Lee, Shin Yup
    Cha, Seung-Ick
    Park, Jae Yong
    Kim, Chang Ho
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, 39 (02) : 318 - 326
  • [4] Malignant Pleural Effusion from Lung Adenocarcinoma Treated by Gefitinib
    Kubo, Akihito
    Koh, Yasuhiro
    Kawaguchi, Tomoya
    Isa, Shun-Ichi
    Okamoto, Isamu
    Fukuoka, Junya
    Kusunoki, Yoko
    Kitaichi, Masanori
    Takada, Minoru
    Nakagawa, Kazuhiko
    INTERNAL MEDICINE, 2011, 50 (07) : 745 - 748
  • [5] Proteomic analysis of human pleural effusion
    Tyan, YC
    Wu, HY
    Su, WC
    Chen, PW
    Liao, PC
    PROTEOMICS, 2005, 5 (04) : 1062 - 1074
  • [6] Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion
    Wu, Shang-Gin
    Liu, Yi-Nan
    Yu, Chong-Jen
    Yang, James Chih-Hsin
    Shih, Jin-Yuan
    GENES CHROMOSOMES & CANCER, 2018, 57 (10) : 513 - 521
  • [7] In vivo and in vitro cell-based model of lung adenocarcinoma from patients with pleural effusion
    Popovic, Mikulas
    Liu, Yiling
    Lattova, Erika
    Mann, Dean
    Curreli, Sabrina
    Zdrahal, Zbynek
    Edelman, Martin
    Bryant, Joseph
    NEOPLASMA, 2021, 68 (03) : 498 - 508
  • [8] A study of the proteomic expression in patients with complicated parapneumonic pleural effusion
    Wu, Xin
    Yang, Wei
    Gou, Xiao-Hua
    Xu, Xiao-Yun
    Lu, Na
    Jian, Shi-Ning
    Han, Yu-Jie
    Lv, Tong-Shuai
    Luo, Li-Zhu
    ARCHIVES OF MEDICAL SCIENCE, 2023, 19 (05) : 1270 - 1280
  • [9] Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion
    Ai, Ling
    Wang, Wenjun
    Li, Jingyuan
    Ye, Ting
    Li, Yuying
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 368 (02) : 136 - 142
  • [10] Prognostic value of aberrant hypermethylation in pleural effusion of lung adenocarcinoma
    Botana-Rial, Maribel
    De Chiara, Loretta
    Valverde, Diana
    Leiro-Fernandez, Virginia
    Represas-Represas, Cristina
    del Campo-Perez, Victor
    Fernandez-Villar, Alberto
    CANCER BIOLOGY & THERAPY, 2012, 13 (14) : 1436 - 1442